Related Experiment Videos
Maternal thrombocytopenia at term: a population-based study.
S Sainio1, R Kekomäki, S Riikonen
1Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Finland.
Acta Obstetricia Et Gynecologica Scandinavica
|September 19, 2000
Summary
Gestational thrombocytopenia is common in pregnancy and usually harmless. No special treatment or fetal blood sampling is needed for this condition at term.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Perinatology
Background:
- Thrombocytopenia (low platelet count) is a frequent complication during pregnancy.
- Maternal thrombocytopenia is often managed inappropriately, necessitating further investigation into its causes and implications.
- Assessing fetal risks associated with maternal thrombocytopenia is crucial.
Purpose of the Study:
- To determine the prevalence and etiological factors of maternal thrombocytopenia at term.
- To investigate the role of immune mechanisms in pregnancy-related thrombocytopenia.
- To evaluate the necessity of assessing fetal risks in cases of maternal thrombocytopenia.
Main Methods:
- A 1-year population-based surveillance study was conducted in Helsinki, involving 4,382 women at term (≥37 weeks gestation) and their infants.
- Maternal and cord blood platelet counts were analyzed at delivery.
- Immune studies were performed for maternal platelet counts below 100 x 10(9)/l, with 95% confidence intervals calculated.
Main Results:
- A total of 7.3% of women (317 out of 4,382) presented with thrombocytopenia (platelet count < 150 x 10(9)/l).
- Gestational thrombocytopenia accounted for 81% of cases and typically had no adverse effects on mother or fetus unless complicated by other disorders.
- Preeclampsia (16%) and idiopathic thrombocytopenic purpura (ITP) (3%) were other identified causes. No significant association was found between maternal and fetal platelet counts.
Conclusions:
- Women diagnosed with gestational thrombocytopenia at term do not require modifications to their standard treatment protocols.
- Routine fetal blood sampling is unnecessary when thrombocytopenia is unexpectedly detected at term, particularly in cases of gestational thrombocytopenia.